Concepedia

Publication | Open Access

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

DOIFull Paper Access

11

Citations

24

References

2018

Year

Maha S. Al-Keilani, Karem H. Alzoubi, Saied A. Jaradat
Clinical Pharmacology Advances and Applications

Abstract

Current results suggest a potential role of NaPB as a sensitizing agent in NSCLC.

References

YearCitations

Page 1